Recently merged CROs Accelovance and Linical rebrand, name new CEO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/tomertu)
(Image: Getty/tomertu)

Related tags: CRO, Accelovance, Linical, Contract research, Contract research organization, Clinical trial

Accelovance and Linical merged in March of this year to create a global midsized CRO for which ‘future possibilities are endless,’ says newly appointed CEO.

The firms merged​ with the goal to create a midsized global contract research organization (CRO) in response to the need for large-scale multinational clinical trials.

Now, the companies have announced that the CRO will operate as Linical Accelovance Group moving forward, led by its new CEO, Vita M. Lanoce, MS. Lanoce was previously the chief operating officer of Accelovance, and has worked at other companies including Covance, Synexus, and Bristol-Myers Squibb.

“I look forward to capitalizing on the talented staff of the Linical Accelovance Group, the extended geographical reach, efficiency of operations and broadening of services the merger has provided,” ​she told us.

According to Lanoce, pharma and biotech sponsors come to the CRO seeking “personal service, flexibility, operational, scientific and medical expertise, and innovative solutions they are not able to get from the mega CROs.”

“Our clients appreciate the personal, hands-on approach of our operations team along with the knowledge that each study will have an executive sponsor to support them, whether the study is a single POC study or a large multi-study clinical development program,”​ she added.

Lanoce said the company plans to continue focusing on early oncology research, while expanding its solutions into additional therapeutic areas.

“The future possibilities for this organization are endless,”​ she said, “including the potential for additional expansion in North and South America as well as Australia, while continuing to enhance our reach in China and APAC.”

Related news

Show more

Related products

show more

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Related suppliers

Follow us


View more